Search

everythinglearnresearchcommunity

for

Search:↓

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Dupilumab effectively reduces symptoms of prurigo nodularis and is safe for long-term use.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Candida antigen is an effective and promising treatment for alopecia areata.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.